Browse All

Current Filters

CLEAR FILTER x

TITLE

Title
    Author Last Name
      Session Name
        Topic
          Program Number
            Author Institution

              Real-world Persistence of Ofatumumab vs Self-injectable or Oral Disease-modifying Therapies in Patients with Multiple Sclerosis

              Author:Hersh, Carrie   Gorritz, Magdaliz   Chen, Chi-Chang   Tuly, Rifat   Gu, Yifan   Shao, Qiujun   Gadkari, Abhijit   Brown, Brandon   

              Session Name:P5: Multiple Sclerosis: Clinical Assessments Including Digital Tools and Outcome Measures 1  

              Topic:Multiple Sclerosis  

              Program Number:P5.012  

              Author Institution:Lou Ruvo Center for Brain Health, Cleveland Clinic, Las Vegas, NV, USA, Las Vegas, NV  IQVIA, Plymouth Meeting, PA, USA, Plymouth Meeting, PA  Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA, East Hanover, NJ  

              Clinical Applications of Digital Biomarkers in Multiple Sclerosis: A Systematic Literature Review

              Author:Cobb, Bryan   Karpowicz, Jr, Richard J.   Cousin, Chris   Win, Nikki   Boggiano, Tina   Jones, David E.   Craveiro, Licinio   Priest, Jessica   Mac, Ami   Teng, Edmond   Dorsey, E. Ray   Sabbagh, Marwan N.   Gudesblatt, Mark   Demaerschalk, Bart M.   Dodick, David W.   

              Session Name:P5: Multiple Sclerosis: Clinical Assessments Including Digital Tools and Outcome Measures 1  

              Topic:Multiple Sclerosis  

              Program Number:P5.013  

              Author Institution:Genentech Inc., Cape Elizabeth, ME  Health Interactions, Inc., Yardley, PA  Genentech Inc., South San Francisco, CA  F. Hoffmann-La Roche Ltd, Basel, Switzerland  University of Rochester, Rochester, NY  Alzheimer's Clinical and Translational Research Lab, Barrow Neurological Institute, St. Joseph's Hospital and Medical Center, Phoenix, AZ  South Shore Neurologic Associates, Patchogue, NY  Mayo Clinic College of Medicine and Science and Center for Digital Health, Phoenix, AZ  Mayo Clinic School of Medicine, Mayo Clinic Arizona, Scottsdale, AZ  

              Sublinical Atherosclerosis in Patients with Relapsing-remitting Multiple Sclerosis: A 5-year Cohort Study

              Author:Omerzu, Tomaz   Karakatic, Sanja   Hojs Fabjan, Tanja   Hojs, Radovan   Gorenjak, Mario   Potocnik, Uros   Magdic, Jozef   

              Session Name:P5: Multiple Sclerosis: Clinical Assessments Including Digital Tools and Outcome Measures 1  

              Topic:Multiple Sclerosis  

              Program Number:P5.014  

              Author Institution:University Medical Centre Maribor, Maribor, Slovenia  Faculty of Medicine University of Maribor, Maribor, Slovenia  

              Prediction of Annualized Relapse Rate at First Clinic Visit Among Patients with Multiple Sclerosis

              Author:Madill, Evan   Healy, Brian   Polgar-Turcsanyi, Mariann   Chitnis, Tanuja   

              Session Name:P5: Multiple Sclerosis: Clinical Assessments Including Digital Tools and Outcome Measures 1  

              Topic:Multiple Sclerosis  

              Program Number:P5.015  

              Author Institution:Brigham and Women's Hospital, Boston, MA  Massachusetts General Hospital, Reading, MA  

              Prediction of Long-term Adherence to Smartphone Sensor-based Tests (Floodlight)

              Author:McGinley, Marisa   Pointeau, Gregoire   Zanon, Mattia   Leocani, Letizia   Comi, Giancarlo   Lipsmeier, Florian   Craveiro, Licinio   Butzkueven, Helmut   

              Session Name:P5: Multiple Sclerosis: Clinical Assessments Including Digital Tools and Outcome Measures 1  

              Topic:Multiple Sclerosis  

              Program Number:P5.016  

              Author Institution:Cleveland Clinic, Mellen Centre, Cleveland, OH  F. Hoffmann-La Roche Ltd, Basel, Switzerland  Vita-Salute San Raffaele University, Milan, Italy  Monash University, Melbourne, Australia